Seattle-based Talus Bio is going after proteins that resist that approach, notably transcription factors, which control which ...

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug ...

The U.S. entered August with more measles cases so far this year than it recorded during all of 2025. With kindergarten MMR coverage down to 92.5% from 95.2% before the pandemic, and Stanford modeling ...

The American Association of Pharmaceutical Scientists (AAPS) will hold its 2026 PharmSci 360 meeting October 25 to 28 at the Ernest N. Morial Convention Center in New Orleans. The event is the ...

The international biotech sector clocked in at $1.37 trillion in 2022 despite headwinds such as slow launches, long-term drug pricing shifts and changing consumer behavior. Recent biotech ...

Vertex Pharmaceuticals Incorporated posted full-year 2024 product revenue of $11.02 billion, a solid 12% increase. The company invested $3.63 billion into R&D during the year and finished 2024 sitting ...

Is AI a risk or an opportunity? Is regulatory divergence a barrier or a catalyst for innovation? The answer depends on how prepared and how agile your organisation is. As regulatory frameworks shift ...

Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...

The pharmaceutical industry heads into 2026 carrying strong M&A momentum, a surging Chinese deal landscape and continued buzz around obesity drugs and new modalities. Deals involving Chinese pharma ...

In 2024, we saw the expanded use of synthetic data and natural language processing transform drug discovery and development. In a batch of predictions published in December of 2023, one expert ...

The U.S. entered August with more measles cases so far this year than it recorded during all of 2025. With kindergarten MMR coverage down to 92.5% from 95.2% before the pandemic, and Stanford modeling ...

Bristol Myers Squibb said Monday it will deploy an NVIDIA DGX SuperPOD, a prepackaged supercomputing platform that NVIDIA sells as a single standard unit, combining multiple compute racks, high-speed ...